Maxillary sarcomas - HABLANI, Hanen
45,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
payback
23 °P sammeln
  • Broschiertes Buch

Bone sarcomas of the maxilla and mandible (SOMM) are rare but serious tumors due to their aggressiveness, complex anatomical localization, diagnostic delays and frequent recurrences. A retrospective study conducted at CHU Habib Bourguiba in Sfax between 2008 and 2018 included 14 patients (mean age 39.7 years, majority male). Mandibular localization was the most frequent (71.5%), and chemotherapy was used as initial treatment in 64.3% of cases, followed by carcinological surgery with reconstruction in 9 patients. Chondroblastic sarcomas were the most common (42.9%), and overall survival at 5…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
Bone sarcomas of the maxilla and mandible (SOMM) are rare but serious tumors due to their aggressiveness, complex anatomical localization, diagnostic delays and frequent recurrences. A retrospective study conducted at CHU Habib Bourguiba in Sfax between 2008 and 2018 included 14 patients (mean age 39.7 years, majority male). Mandibular localization was the most frequent (71.5%), and chemotherapy was used as initial treatment in 64.3% of cases, followed by carcinological surgery with reconstruction in 9 patients. Chondroblastic sarcomas were the most common (42.9%), and overall survival at 5 years was 41.8%, with unfavorable prognostic factors such as smoking (p=0.043), advanced age and maxillary locations (p=0.010). Despite therapeutic efforts, the prognosis of SOMM remains poor, whatever the histological type.
Autorenporträt
Hablani Hanene é assistente hospitalar universitária em Estomatologia e Cirurgia no CHU Habib Bourguiba Sfax, Tunísia.